Piotr Roszczenko

Mr. Piotr Roszczenko

Medical University of Białystok, Bialystok, Poland
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RCRobert Czarnomysy
Robert Czarnomysy
Dominika Wioletta RadomskaDominika Wioletta Radomska
Dominika Wioletta Radomska
OSOlga Klaudia Szewczyk-Roszczenko
Olga Klaudia Szewczyk-Roszczenko
Piotr RoszczenkoPiotr Roszczenko
Piotr Roszczenko
KBKrzysztof Bielawski
Krzysztof Bielawski
There is a need for new, safer, and more effective agents to treat cancer. Cytostatics that have transition metals at their core have attracted renewed interest from scientists. Researchers are attempting to use chemotherapeutics, such as cisplatin, in combination therapy (i.e., in order to enhance their effectiveness). Moreover, studies are being carried out to modify molecules, by developing them into multinuclear structures, linking different compounds to commonly used drugs, or encapsulating them in nanoparticles to improve pharmacokinetic parameters, and increase the selectivity of these drugs. Therefore, we attempted to organize recent drug findings that contain palladium and platinum atoms in their structures.

Verified
Journal Article
Open access
PDF file
Piotr RoszczenkoPiotr Roszczenko
Piotr Roszczenko
Serhii HolotaSerhii Holota
Serhii Holota
OSOlga Klaudia Szewczyk-Roszczenko
Olga Klaudia Szewczyk-Roszczenko
RDRostyslav Dudchak
Rostyslav Dudchak
KBKrzysztof Bielawski
Krzysztof Bielawski
Roman LesykRoman Lesyk
Roman Lesyk
Oncological diseases have currently reached an epidemic scale, especially in industrialized countries. Such a situation has prompted complex studies in medicinal chemistry focused on the research and development of novel effective anticancer drugs. In this review, the data concerning new 4-thiazolidinone-bearing hybrid molecules with potential anticancer activity reported during the period from the years 2017–2022 are summarized. The main emphasis is on the application of molecular hybridization methodologies and strategies in the design of small molecules as anticancer agents. Based on the analyzed data, it was observed that the main directions in this field are the hybridization of scaffolds, the hybrid-pharmacophore approach, and the analogue-based drug design of 4-thiazolidinone cores with early approved drugs, natural compounds, and privileged heterocyclic scaffolds. The mentioned design approaches are effective tools/sources for the generation of hit/lead compounds with anticancer activity and will be relevant to future studies.

19 September 2023 in Cells
Verified
Journal Article
Open access
PDF file
OSOlga Klaudia Szewczyk-Roszczenko
Olga Klaudia Szewczyk-Roszczenko
Piotr RoszczenkoPiotr Roszczenko
Piotr Roszczenko
ASAnna Shmakova
Anna Shmakova
Nataliya FiniukNataliya Finiuk
Nataliya Finiuk
Serhii HolotaSerhii Holota
Serhii Holota
KBKrzysztof Bielawski
Krzysztof Bielawski
Endocytosis is one of the major ways cells communicate with their environment. This process is frequently hijacked by pathogens. Endocytosis also participates in the oncogenic transformation. Here, we review the approaches to inhibit endocytosis, discuss chemical inhibitors of this process, and discuss potential clinical applications of the endocytosis inhibitors.

Verified
Journal Article
Open access
PDF file
OSOlga Klaudia Szewczyk-Roszczenko
Olga Klaudia Szewczyk-Roszczenko
Piotr RoszczenkoPiotr Roszczenko
Piotr Roszczenko
RCRobert Czarnomysy
Robert Czarnomysy
ABAnna Bielawska
Anna Bielawska
KBKrzysztof Bielawski
Krzysztof Bielawski
Several authorities have implied that nanotechnology has a significant future in the development of advanced cancer therapies. Nanotechnology makes it possible to simultaneously administer drug combinations and engage the immune system to fight cancer. Nanoparticles can locate metastases in different organs and deliver medications to them. Using them allows for the effective reduction of tumors with minimal toxicity to healthy tissue. Transition-metal nanoparticles, through Fenton-type or Haber–Weiss-type reactions, generate reactive oxygen species. Through oxidative stress, the particles induce cell death via different pathways. The main limitation of the particles is their toxicity. Certain factors can control toxicity, such as route of administration, size, aggregation state, surface functionalization, or oxidation state. In this review, we attempt to discuss the effects and toxicity of transition-metal nanoparticles.

21 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
IIIryna Ivasechko
Iryna Ivasechko
Ihor YushynIhor Yushyn
Ihor Yushyn
Piotr RoszczenkoPiotr Roszczenko
Piotr Roszczenko
JSJulia Senkiv
Julia Senkiv
Nataliya FiniukNataliya Finiuk
Nataliya Finiuk
Roman LesykRoman Lesyk
Roman Lesyk
Novel pyridine-thiazole hybrid molecules were synthesized and subjected to physico-chemical characterization and screening of their cytotoxic action towards a panel of cell lines derived from different types of tumors (carcinomas of colon, breast, and lung, glioblastoma and leukemia), and normal human keratinocytes, for comparison. High antiproliferative activity of the 3-(2-fluorophenyl)-1-[4-methyl-2-(pyridin-2-ylamino)-thiazol-5-yl]-propenone 3 and 4-(2-{1-(2-fluorophenyl)-3-[4-methyl-2-(pyridin-2-ylamino)-thiazol-5-yl]-3-oxopropylsulfanyl}-acetylamino)-benzoic acid ethyl ester 4 was revealed. The IC50 of the compound 3 in HL-60 cells of the acute human promyelocytic leukemia was 0.57 µM, while in the pseudo-normal human cell lines, the IC50 of this compound was >50 µM, which suggests that the compounds 3 and 4 might be perspective anticancer agents. The detected selectivity of the derivatives 3 and 4 for cancer cell lines inspired us to study the mechanisms of their cytotoxic action. It was shown that preincubation of tumor cells with Fluzaparib (inhibitor of PARP1) reduced the cytotoxic activity of the derivatives 3 and 4 by more than twice. The ability of these compounds to affect DNA nativity and cause changes in nucleus morphology allows for the suggestion that the mechanism of action of the novel pyridine-thiazole derivatives might be related to inducing the genetic instability in tumor cells.

25 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Piotr RoszczenkoPiotr Roszczenko
Piotr Roszczenko
OSOlga Klaudia Szewczyk-Roszczenko
Olga Klaudia Szewczyk-Roszczenko
RCRobert Czarnomysy
Robert Czarnomysy
KBKrzysztof Bielawski
Krzysztof Bielawski
ABAnna Bielawska
Anna Bielawska
Nanomedicine is a potential provider of novel therapeutic and diagnostic routes of treatment. Considering the development of multidrug resistance in pathogenic bacteria and the commonness of cancer, novel approaches are being sought for the safe and efficient synthesis of new nanoparticles, which have multifaceted applications in medicine. Unfortunately, the chemical synthesis of nanoparticles raises justified environmental concerns. A significant problem in their widespread use is also the toxicity of compounds that maintain nanoparticle stability, which significantly limits their clinical use. An opportunity for their more extensive application is the utilization of plants, fungi, and bacteria for nanoparticle biosynthesis. Extracts from natural sources can reduce metal ions in nanoparticles and stabilize them with non-toxic extract components.